News Focus
News Focus
icon url

Pyrrhonian

10/25/14 10:45 AM

#21954 RE: Pyrrhonian #21953

Poster Presentations / Staffing Hours

Odd Number Posters (authors are present)
Friday, November 7, 12:30 pm – 2:00 pm* and 6:10 pm – 7:30 pm


Even Number Posters (authors are present)
Saturday, November 8 from 12:30 pm – 2:00 pm* and 6:10 pm – 7:30 pm

*Note: Lunch and poster viewing is available to meeting attendees on Friday, November 7 and Saturday, November 8 between 12:30 pm and 2:00 pm. Although poster presentations are scheduled for only one lunch period, presenters are welcome to stand by posters for both lunch periods (Friday AND Saturday) if they so desire.

Extend the Life of your Poster
The Society for Immunotherapy of Cancer (SITC) is collaborating with F1000Posters, an established open-access poster repository, to extend the visibility of meeting posters beyond the SITC 2014 audience. More information regarding this opportunity and how to deposit your work will be provided by SITC following the conclusion of SITC 2014.

Reminder:
All abstract content is embargoed until 8:00 am EST on Tuesday, November 4, 2014.

icon url

Pyrrhonian

10/25/14 10:59 AM

#21956 RE: Pyrrhonian #21953

Abstract guidelines:

-Verify the data presented in the abstract has not been published prior to November 6, 2014, or if previously published contains significant new data.

-Agree that the abstract submitted to the SITC 29th Annual Meeting is embargoed until 8:00 am EST on November 4, 2014

-Agree that, if accepted, the noted presenting author or a co-author will present the abstract at the 29th Annual Meeting.

icon url

rrflyboy

10/25/14 2:40 PM

#21964 RE: Pyrrhonian #21953

Pyrr and/or Flip,
In reviewing the SITC seminar schedule a series of "Hot Topics" breakout sessions on 11/19 look interesting to me for DCVax implications. Being a layperson on this science I wonder if you could enlighten with your expertise if this one has Roche looking in our direction:

"511 – Hot Topic Symposium I: Accelerating Tumor Immunity with Agonist Antibodies
Anti-CD40 Agonist Antibody - The Ideal Combination Partner for Cancer Immunotherapy

calendar11/9/2014clock11:20 AM - 11:45 AMclockRoom: Woodrow Wilson A
Hy Levitsky, MD
Global Head, Cancer Immunology Experimental Medicine, Roche Pharma Research and Early Development, Schlieren 8952, Switzerland"

Thanks in advance.
icon url

Evaluate

11/01/14 3:16 PM

#22298 RE: Pyrrhonian #21953

Will there be 2 posters?
Poster 61 & Poster 75?

P61 Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment

P75 A pilot study of Ipilimumab in patients with stage IV melanoma receiving palliative radiation therapy

Looks like Poster 75 does not apply to NWBO.

Also:
http://eventscribe.com/2014/sitc/aaFAQ.asp
On what date will the abstracts be published?
All abstracts submitted to the SITC 29th Annual Meeting will be published in the Journal for ImmunoTherapy of Cancer, the official journal of SITC. This issue will be released on Thursday, November 6, 2014.